DataMEDS AI, Inc. (MEDS) Stock Analysis & Investment Frameworks
DataMEDS AI, Inc. (MEDS) stock analysis on Invetso. Review DataMEDS AI, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
DataMEDS AI, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Distribution
- Country: US
DataMEDS AI, Inc. Key Financial Metrics
- Market Cap: $6.90M
- Revenue: $23.34M
- ROE: 877.58%
- ROIC: -439.90%
- Dividend Yield: N/A
About DataMEDS AI, Inc.
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
DataMEDS AI, Inc. Investment Frameworks
Invetso analyzes DataMEDS AI, Inc. (MEDS) across the following frameworks:
- DataMEDS AI, Inc. 10Y Growth Potential
- DataMEDS AI, Inc. Scenario Analysis
- DataMEDS AI, Inc. Risks & Opportunities
- DataMEDS AI, Inc. Economic Moat
- DataMEDS AI, Inc. Business Model
- DataMEDS AI, Inc. Management
- DataMEDS AI, Inc. SWOT Analysis
- DataMEDS AI, Inc. Porter's 5 Forces
- DataMEDS AI, Inc. PESTLE Analysis
- DataMEDS AI, Inc. ESG Analysis